Emerging and Re emerging Infectious Diseases
Emerging infectious diseases are new to humans or are rapidly spreading to new places. Re-emerging diseases are known infections, such as measles, dengue or tuberculosis, that return after being under control. Both can spread quickly in a connected world.
The Emerging and Re emerging Infectious Diseases session at Infectious 2027 brings together clinicians, scientists and public health experts to share research on new and returning threats. It connects closely with infectious disease surveillance and epidemiology, which helps detect outbreaks early.
Most new infections in people come from animals, often when people move into new areas or handle wildlife. Travel and trade can carry them around the world within days. Known diseases can also return when vaccination drops or drug resistance grows. Fast detection and response are key to stopping small outbreaks from becoming large ones.
Key Topics in Emerging and Re emerging Infectious Diseases
• Zoonotic spillover and new pathogens
• Re-emergence of vaccine-preventable diseases
• Dengue, chikungunya and other arboviruses
• Avian and pandemic influenza
• Mpox and other re-emerging viruses
• Drug-resistant tuberculosis
• Outbreak investigation and response
• Pandemic preparedness planning
• Travel, trade and disease spread
• One Health approaches to emerging threats
Recent Advances in Emerging and Re emerging Infectious Diseases
Genomic sequencing now allows new pathogens to be identified and tracked within days, using tools covered in molecular biology and genomics. Wastewater testing and digital surveillance are giving early warnings before cases rise in hospitals.
Changes in climate and land use are bringing people and animals into closer contact, a theme explored in climate change and infectious diseases. Fast vaccine platforms developed during COVID-19, discussed in vaccine development and immunization, are improving readiness for the next pandemic.
Shared genomic data is helping countries spot and track new threats faster than ever. Rapid response teams are being trained and deployed across regions. Research is focusing on where spillover from animals is most likely. Lessons from recent outbreaks are being built into national plans.
Who Should Attend the Emerging and Re emerging Infectious Diseases Session
• Infectious disease physicians and specialists
• Epidemiologists and public health officers
• Virologists and microbiologists
• Outbreak response and preparedness teams
• PhD students and early-career researchers
• Veterinary and One Health professionals
Why Present Your Research in Emerging and Re emerging Infectious Diseases
Presenting at Infectious 2027 puts your research in front of an international audience in Singapore and online. You can share outbreak lessons and connect with colleagues working in global health and infectious diseases to strengthen preparedness worldwide. Outbreak experience is valuable when shared quickly. Presenting here helps other teams prepare for similar threats.
Frequently Asked Questions
Can I present an outbreak investigation report?
Yes. Outbreak investigations with clear methods and lessons are welcome.
Where and when is Infectious 2027?
Infectious 2027 takes place from 11 to 13 March 2027 at Village Hotel Changi, Singapore, with online participation available.
Can students present in this session?
Yes. Students and early-career researchers are encouraged to submit abstracts.